TBC1D22A-TRMU Fusion FISH Probe
The TBC1D22A-TRMU Fusion FISH Probe is used to confirm a fusion of the TBC1D22A and TRMU genes. The fusion of the TBC1D22A and TRMU genes has been associated with Esophageal Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TBC1D22A-TRMU-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TBC1D22A-TRMU-20-AQAQ | 20 (40 μL) | 200 μL |
|
TBC1D22A Gene Summary
The TBC1 Domain Family Member 22A (TBC1D22A) gene is located on chr22 :47158517-47571342 at 22q13.31.
Gene Name: TBC1 Domain Family Member 22A
Chromosome: CHR22: 47158517 -47571342
Locus: 22q13.31
TRMU Gene Summary
This nuclear gene encodes a mitochondrial tRNA-modifying enzyme. The encoded protein catalyzes the 2-thiolation of uridine on the wobble positions of tRNA(Lys), tRNA(Glu), and tRNA(Gln), resulting in the formation of 5-taurinomethyl-2-thiouridine moieties. Mutations in this gene may cause transient infantile liver failure. Polymorphisms in this gene may also influence the severity of deafness caused by mitochondrial 12S ribosomal RNA mutations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Gene Name: TRNA 5-methylaminomethyl-2-thiouridylate Methyltransferase
Chromosome: CHR22: 46731297 -46753237
Locus: 22q13.31
Gene Diseases
The TBC1D22A TRMU Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Esophageal Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|